PHARMASEED, MODEL BT-103-2— 510(k) K993700

Name: FDA 510(k) clearance K993700
Creator: U.S. Food and Drug Administration
Published: 2000-06-02

Substantially Equivalent

Syncor International, Inc.

FDA 510(k) clearance K993700 for PHARMASEED, MODEL BT-103-2, Substantially Equivalent on 2000-06-02. Applicant: Syncor International, Inc.. Device class: 2.

Clearance details

Applicant: Syncor International, Inc.
Product code: Code KXK
Device class: Class 2
Regulation: 21 CFR 892.5730
Advisory panel: Radiology
Date received: 1999-11-02
Decision date: 2000-06-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Golden, CO, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KXK

view all

K252296 — OncoPatch2025-12-05
K242818 — IsoSphere2025-07-15
K223465 — RadianceTx Radionuclide Brachytherapy Source2023-01-11
K221539 — GammaTile2022-11-09
K202267 — Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles2020-12-31

More clearances from Syncor International, Inc.

view all

K993701 — PHARMASEED, MODEL BT-125-22000-06-09

Data sourced from openFDA. This site is unofficial and independent of the FDA.